Former FDA Oncology Reviewer Emily Place PhD MPH offers her inside perspective on IND review timelines and what drives the multidisciplinary team up to the 30 day deadline.
Join us for this brief webinar sponsored by Biologics Consulting.

Register for this webinar on Microsoft Virtual Events Powered by Teams.